Niagen Bioscience Inc (NAGE) Profit Margin
Niagen Bioscience Inc (NAGE) net profit margin by fiscal period. Analyze profit margins in Excel with MarketXLS.
Profit Margin Data
| Period | Net Profit Margin |
|---|---|
| 2016-12-31 | -13.52% |
| 2017-12-31 | -53.67% |
| 2018-12-31 | -105.57% |
| 2019-12-31 | -69.45% |
| 2020-12-31 | -33.62% |
| 2021-12-31 | -40.22% |
| 2022-12-31 | -22.96% |
| 2023-12-31 | -5.91% |
| 2024-12-31 | 8.58% |
| 2025-12-31 | 13.43% |
How NAGE compares with sector peers
| Symbol | Company | Net profit margin (latest fiscal year) |
|---|---|---|
| BSX | Boston Scientific Corporation | 14.44% |
| MDT | Medtronic plc. | 13.20% |
| STE | STERIS plc (Ireland) | 13.18% |
| VCYT | Veracyte Inc. | 12.83% |
| PFE | Pfizer Inc. | 12.42% |
These are five companies in the same sector as NAGE with a comparable annual net profit margin. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Niagen Bioscience Inc Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Profit_Margin("NAGE", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | NAGE | $3.17 | +3.59% | 0.81M |
| 3 | ||||
| 4 | ||||
| 5 |